4//SEC Filing
Frueh Klaus 4
Accession 0001209191-19-053661
CIK 0001706431other
Filed
Oct 17, 8:00 PM ET
Accepted
Oct 18, 7:50 PM ET
Size
8.1 KB
Accession
0001209191-19-053661
Insider Transaction Report
Form 4
Frueh Klaus
Director
Transactions
- Conversion
Common Stock
2019-10-16+218,400→ 362,844 total(indirect: See footnote) - Conversion
Series A-2 Convertible Preferred Stock
2019-10-16−218,400→ 0 total(indirect: See footnote)→ Common Stock (218,400 underlying)
Holdings
- 77,777
Common Stock
Footnotes (2)
- [F1]Each share of the Issuer's Series A-2 Convertible Preferred Stock (the "Preferred Stock") automatically converted into one share of the Issuer's common stock upon the closing of the Issuer's initial public offering. The Preferred Stock had no expiration date.
- [F2]The shares are held in the name of the Klaus and Renate Frueh Revocable Trust Dated June 26, 2017.
Documents
Issuer
Vir Biotechnology, Inc.
CIK 0001706431
Entity typeother
Related Parties
1- filerCIK 0001786308
Filing Metadata
- Form type
- 4
- Filed
- Oct 17, 8:00 PM ET
- Accepted
- Oct 18, 7:50 PM ET
- Size
- 8.1 KB